NEW YORK (AP) _ Progenics Pharmaceuticals Inc. (PGNX) on Thursday reported a loss of $18.7 million in its first quarter.
The New York-based company said it had a loss of 22 cents per share.
The biopharmaceutical company posted revenue of $4.3 million in the period.
Progenics shares have increased 24% since the beginning of the year. The stock has dropped 25% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PGNX at https://www.zacks.com/ap/PGNX